Difference between TIVA and TCI for My MD Anaesthesiology exam
TIVA vs TCI anaesthesia difference MD exam pharmacokinetics pharmacodynamics
TIVA vs TCI difference pharmacokinetics models advantages disadvantages
| TIVA | TCI | |
|---|---|---|
| Full form | Total IntraVenous Anaesthesia | Target Controlled Infusion |
| Definition | A technique in which ALL anaesthetic agents (hypnotic + analgesic + relaxant) are given intravenously, with NO volatile agents | A method of drug delivery that uses a microprocessor and pharmacokinetic (PK) model to achieve and maintain a clinician-specified target drug concentration in a body compartment |
| Key concept | Describes the route of administration | Describes the mode of infusion (PK-controlled) |
| Relationship | TIVA can be performed with or without TCI; TCI is the most precise way to deliver TIVA | TCI is a subset/tool within TIVA |
Important exam point: TCI is NOT synonymous with TIVA. TIVA is a broader concept (all IV anaesthesia). TCI is a delivery method that can be used to achieve TIVA. You can have TIVA without TCI (manual infusion), but TCI in anaesthesia is almost always used as part of TIVA.

| Plasma targeting (Cp) | Effect-site targeting (Ce) | |
|---|---|---|
| What is targeted | Drug concentration in blood | Drug concentration at the brain (biophase) |
| Behavior at induction | Target must be deliberately set higher to achieve faster Ce rise; risk of overshoot | Pump auto-overshoots Cp to rapidly drive Ce up - no need to adjust target |
| Steady state | Cp and Ce eventually equilibrate (there is a lag - hysteresis) | More directly correlates with clinical effect |
| Preferred for | Less experienced users; safer in hemodynamically unstable | Preferred clinically; smoother induction |
| Feature | Marsh | Schnider |
|---|---|---|
| V1 | Variable (larger) | Fixed 4.27 L |
| Covariates | Weight only | Weight, age, height, LBM |
| Default target | Plasma Cp | Effect-site Ce |
| Induction | Faster (larger V1, larger bolus) | Slower, more controlled |
| Drug use | More propofol | Less total propofol |
| Age adjustment | No | Yes |
| Parameter | TIVA (Manual) | TCI |
|---|---|---|
| Basis of dosing | Body weight (mg/kg), empirical | PK model (3-compartment), targets concentration |
| What clinician sets | Infusion rate (mL/hr or mg/kg/hr) | Target concentration (mcg/mL or ng/mL) |
| Real-time Cp/Ce estimate | No | Yes (predicted) |
| Drug accumulation risk | Higher (no auto-correction) | Lower (algorithm corrects continuously) |
| Titration | Manual - requires calculation | Automated - pump adjusts rates |
| Induction | Bolus + start infusion | Pump gives auto-calculated loading bolus |
| Equipment needed | Standard syringe pump | Dedicated TCI pump with PK software |
| Operator skill | Higher (manual calculation needed) | Lower (algorithm does the work) |
| Accuracy | Less (population PK assumptions) | Better but still uses population models |
| Awareness risk | Higher (variable concentrations) | Lower (more stable concentrations) |
| Cost | Lower | Higher |
| Paediatrics | Standard (most children get this) | Limited (adult models valid >16 yr, >30 kg) |
| Feature | TIVA | Volatile |
|---|---|---|
| PONV | Much lower | Higher |
| Environment | No pollution | Theatre/gas pollution |
| Awareness | Slightly higher risk | Lower |
| ICP/CBF | Lower (propofol reduces CBF) | May increase (esp. >1 MAC) |
| Malignant hyperthermia | Safe | Triggers MH |
| Recovery | Faster with remifentanil | Variable |
| TIVA monitoring (Expired concentration) | Not measurable | Direct (agent analyser) |